{
    "nctId": "NCT02035085",
    "briefTitle": "19F Hot Spot MRI of Human Adipose-derived Stem Cells for Breast Reconstruction",
    "officialTitle": "This is a First-in-man, Phase I Study Utilizing 19F Magnetic Resonance Imaging (MRI) to Track Autologous, Adipose Derived Stem Cells.",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "19F MRI signal over time",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patient capable and willing to sign the Informed Consent (see attached document)\n2. Patient must be willing to complete all visits in this study\n3. Female, \\>18 years of age\n4. Lumpectomy and radiation therapy for breast carcinoma\n5. 18 month disease free survival\n6. No evidence of metastatic disease\n7. Patient is fit for surgery as determined by preoperative medical clearance workup performed by an independent primary care physician.\n8. Negative pregnancy test.\n\nExclusion Criteria:\n\n1. Evidence of metastatic disease\n2. Less than 18 months disease-free interval\n3. Unable to undergo MRI:\n\n3a) Metallic implant 3b) Claustrophobic 4) High risk for surgical intervention because of comorbidities 5) Received treatment with an investigational drug within 30 days of screening.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}